About gLeaf
gLeaf is a company based in Frederick (United States) founded in 2014 was acquired by Columbia Care in December 2020. gLeaf has raised $19.45 million across 8 funding rounds from investors including Chicago Atlantic and Columbia Care. The company has 230 employees as of December 31, 2022. gLeaf operates in a competitive market with competitors including Sanity Group, ZYUS Life Sciences, Terraflos, Avicanna and Tetra Bio-Pharma, among others.
- Headquarter Frederick, United States
- Employees 230 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Green Leaf Medical, Llc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$19.45 M (USD)
in 8 rounds
-
Latest Funding Round
$10 M (USD), Debt – Conventional
Apr 27, 2020
-
Investors
Chicago Atlantic
& 1 more
-
Employee Count
230
as on Dec 31, 2022
-
Acquired by
Columbia Care
(Dec 22, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of gLeaf
gLeaf has successfully raised a total of $19.45M across 8 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $10 million completed in April 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in gLeaf
gLeaf has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Chicago Atlantic and Columbia Care.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Working capital and real estate loans are provided to businesses.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for gLeaf
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by gLeaf
Investment portfolio details for gLeaf
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - gLeaf
Detailed financials for gLeaf
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Gleaf Comparisons
Peer comparison for gLeaf
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of gLeaf
gLeaf operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sanity Group, ZYUS Life Sciences, Terraflos, Avicanna and Tetra Bio-Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of cannabinoid-based pharmaceuticals and well-being products
|
|
| Locked | Locked | Locked |
Cannabis-derived therapeutics for multiple indications are developed.
|
|
| Locked | Locked | Locked |
Medical cannabis products are provided based on GMP processes.
|
|
| Locked | Locked | Locked |
Plant-derived cannabinoid products are developed for medical and consumer uses.
|
|
| Locked | Locked | Locked |
Natural medicinal plant-based elements are developed for treating multiple diseases.
|
|
| Locked | Locked | Locked |
Manufacturer of medicinal cannabis for therapeutic use
|
Detailed competitors of gLeaf
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Gleaf
Complete news archive for gLeaf
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about gLeaf
gLeaf was founded in 2014 and raised its 1st funding round 3 years after it was founded.
gLeaf is headquartered in Frederick, United States. It is registered at Frederick, Maryland, United States.
gLeaf is a funded company, having raised a total of $19.45M across 8 funding rounds to date.
As of Dec 31, 2022, the latest employee count at gLeaf is 230.
gLeaf was founded in 2014 and is based in Frederick, United States. Operations focus on the medical cannabis sector, where various varieties of cannabis flowers are grown. Products are supplied to dispensaries following the award of a stage 2 cultivation license. Cultivation activities are conducted under regulated conditions to meet medical standards.
gLeaf's top competitors include Avicanna, ZYUS Life Sciences and Sanity Group.
gLeaf has 2 investors. Key investors include Chicago Atlantic, and Columbia Care.